This article is a correction to:
Biomarkers (mRNAs and Non-Coding RNAs) for the Diagnosis and Prognosis of Colorectal Cancer – From the Body Fluid to Tissue Level
Jinhua He
Feifeng Wu2†- 1Department of Laboratory Medicine, Central Hospital of Panyu District, Guangzhou, China
- 2Department of Hepatobiliary Surgery, The First Affiliated Hospital of Jinan University, Guangzhou, China
A Corrigendum on
Biomarkers (mRNAs and non-coding RNAs) for the diagnosis and prognosis of colorectal cancer - from the body fluid to tissue level
He J, Wu F, Han Z, Hu M, Lin W, Li Y and Cao M (2021). Front. Oncol. 11:632834. doi: 10.3389/fonc.2021.632834
In the published article, there was an error. There is a clerical error in our article. On the page 5, the word “increase” should actually be “decrease”. So, it should read, “The upregulation of CCAT1 expression decreases sensitivity to fluorouracil chemotherapy, whereas its downregulation effectively reverses the resistance of colon cancer cell lines to fluorouracil, thereby opening up a new approach for the treatment of colon cancer.”
A correction has been made to Candidate RNA Molecules as Biomarkers for CRC.
lncRNAs as Biomarkers for CRC, Paragraph 3. This sentence previously stated:
“The upregulation of CCAT1 expression increases sensitivity to fluorouracil chemotherapy, whereas its downregulation effectively reverses the resistance of colon cancer cell lines to fluorouracil, thereby opening up a new approach for the treatment of colon cancer.”
The corrected sentence appears below:
“The upregulation of CCAT1 expression decreases sensitivity to fluorouracil chemotherapy, whereas its downregulation effectively reverses the resistance of colon cancer cell lines to fluorouracil, thereby opening up a new approach for the treatment of colon cancer.”
The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.
Publisher’s note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.
Keywords: colorectal cancer, circulating tumor cell, circulating tumor DNA, circulating tumor miRNA, exosomes
Citation: He J, Wu F, Han Z, Hu M, Lin W, Li Y and Cao M (2024) Corrigendum: Biomarkers (mRNAs and non-coding RNAs) for the diagnosis and prognosis of colorectal cancer - from the body fluid to tissue level. Front. Oncol. 14:1476176. doi: 10.3389/fonc.2024.1476176
Received: 23 August 2024; Accepted: 30 August 2024;
Published: 13 September 2024.
Edited and Reviewed by:
Liang Qiao, The University of Sydney, AustraliaCopyright © 2024 He, Wu, Han, Hu, Lin, Li and Cao. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Mingrong Cao, tcaomr@163.com; Yuguang Li, lyg_py@126.com
†These authors have contributed equally to this work